Role of mitochondrial membrane permeability transition in p-hydroxybenzoate ester-induced cytotoxicity in rat hepatocytes

Biochemical Pharmacology

Volumn 58, Issue 5, 1999, Pages 811-816

  Nakagawa, Yoshio ^a   Moore, Gregory ^b  

^a TOKYO METROPOLITAN INSTITUTE OF PUBLIC HEALTH   (Japan)

^b Natl Chem Inspectorate S 171 27 ^*  (Sweden)

Author keywords

Antimicrobial preservative; Cytotoxicity; Mitochondrial dysfunction; Mitochondrial permeability transition; p hydroxybenzoate esters; Parabens

Indexed keywords

4 HYDROXYBENZOIC ACID ESTER; BUTYL PARABEN; CYCLOSPORIN A; ETHYL PARABEN; HYDROXYBENZOIC ACID DERIVATIVE; METHYL PARABEN; PROPYL PARABEN; TRIFLUOPERAZINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; LIVER CELL; LIVER MITOCHONDRION; MALE; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL DEATH; INTRACELLULAR MEMBRANES; LIVER; MALE; MITOCHONDRIA, LIVER; PARABENS; PERMEABILITY; RATS; RATS, INBRED F344;

EID: 0032807914     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00147-1     Document Type: Article

References (34)

1. Matthews C., Davidson J., Bauer E., Morrison J.L., Richardson A.P. p-Hydroxybenzoic acid esters as preservatives. II. Acute and chronic toxicity in dogs, rats, and mice. J Am Pharm Assoc. 45:1956;260-267.
2. Final report on the safety assessment of methylparaben, ethylparaben, propylparaben, and butylparaben. J Am Coll Toxicol 3: 147-209, 1984.
3. Inai K., Aoki Y., Akamizu H., Eto R., Nishida T., Tokuoka S. Tumorigenicity study of butyl and isobutyl p-hydroxybenzoates administered orally to mice. Food Chem Toxicol. 23:1985;575-578.
4. McCann J., Choi E., Yamasaki E., Ames B.N. Detection of carcinogens as mutagens in the Salmonella/microsome test Assay of 300 chemicals . Proc Natl Acad Sci USA. 72:1975;5135-5139.
5. Food and Drug Research Laboratories (FDRL), Teratologic evaluation of FDA 71-38 (methyl paraben). US NTIS PB report (PB-221, 785), 1972.
6. Nakagawa Y., Moldéus P. Mechanism of p-hydroxy benzoate ester-induced mitochondrial dysfunction and cytotoxicity in isolated rat hepatocytes. Biochem Pharmacol. 55:1988;1907-1914.
7. Kehrer J.P., Jones D.P., Lemasters J.J., Farber J.L., Jaeschke H. Contemporary issue in toxicology Mechanisms of hypoxic cell injury . Toxicol Appl Pharmacol. 106:1990;165-178.
8. 2+ release. Arch Biochem Biophys. 195:1979;453-459.
9. 2+ cycling in cytotoxicity. Biochem Pharmacol. 44:1992;1995-2003.
10. Nieminen A.-L., Saylor A.K., Tesfai S.A., Herman B., Lemasters J.J. Contribution of the mitochondrial permeability transition to lethal injury after exposure of hepatocytes to t-butylhydroperoxide. Biochem J. 307:1995;99-106.
11. Bosser B., Gores G. Liver cell necrosis Cellular mechanisms and clinical implications . Gastroenterology. 108:1995;252-275.
12. Zoratti M., Szabo I. The mitochondrial permeability transition. Biochim Biophys Acta. 1241:1995;139-176.
13. Cain K., Skilleter D.N. Preparation and use of mitochondria in toxicological research. Snell K., Mullock B. Biochemical Toxicology, a Practical Approach. 1987;217-254 IRL Press, Oxford.
14. Petronilli V., Constantini P., Scorrano L., Colonna R., Passamonti S., Bernardi P. The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols. Increase of the gating potential by oxidants and its reversal by reducing agents. J Biol Chem. 269:1994;16638-16642.
15. Moldéus P., Hogberg J., Orrenius S. Isolation and use of liver cells. Methods Enzymol. 52:1978;60-71.
16. Imberti R., Nieminen A.-L., Herman B., Lemasters J.J. Mitochondrial and glucolytic dysfunction in lethal injury to hepatocytes by t-butylhydroperoxide Protection by fructose, cyclosporin A and trifluoperazine . J Pharmacol Exp Ther. 265:1993;392-400.
17. Lemasters J.J., Nieminen A.-L., Chacon E., Imberti R., Gores G., Reece J.M., Herman B. Use of fluorescent probes to monitor mitochondrial membrane potential in isolated mitochondria, cell suspensions, and cultured cells. Lash L.H., Jones D.P. Mitochondrial Dysfunction. 1993;404-415 Academic Press, San Diego.
18. Jones D.P. Determination of pyridine dinucleotides in cell extracts by high-performance liquid chromatography. J Chromatogr. 225:1998;446-449.
19. Fournier N., Ducent G., Crevat A. Action of cyclosporin on mitochondrial calcium fluxes. J Bioenerg Biomembr. 19:1987;297-303.
20. 2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J. 255:1988;357-360.
21. Trost L.C., Lemasters J.J. The mitochondrial permeability transition A new pathophysiological mechanism for Reye's syndrome and toxic liver injury . J Pharmacol Exp Ther. 278:1996;1000-1005.
22. Hansch C., Dunn W.J. III. Linear relationships between lipophilic character and biological activity of drugs. J Pharm Sci. 61:1972;1-19.
23. Lyon R.C., McComb J.A., Schreurs J., Goldstein D.B. A relationship between alcohol intoxication and the disordering of brain membranes by a series of short-chain alcohols. J Pharmacol Exp Ther. 218:1981;669-675.
24. Bernardi P., Broekmeier K.M., Pfeiffer D.R. Recent progress on regulation of the mitochondrial permeability transition pore A cyclosporin sensitive pore in the inner mitochondrial membrane . J Bioenerg Biomembr. 26:1994;509-517.
25. Gunter T.E., Pfeiffer D.R. Mechanisms by which mitochondria transport calcium. Am J Physiol. 258:1990;C755-C786.
26. Broekemeier K.M., Pfeiffer D.R. Inhibition of the mitochondrial permeability transition by cyclosporin A during long time frame experiments Relationship between pore opening and the activity of mitochondrial phospholipases . Biochemistry. 34:1995;16440-16449.
27. Gunter T., Gunter K.K., Sheu S.-S., Gavin C.E. Mitochondrial calcium transport Physiological and pathological relevance . Am J Physiol. 276:1994;C313-C339.
28. Lemasters J.J., Nieminen A.-L., Qian T., Trost L.C., Herman B. The mitochondrial permeability transition in toxic, hypoxic and reperfusion injury. Mol Cell Biochem. 174:1997;159-165.
29. Pastorino J.G., Snyder J.W., Serroni A., Hoek J.B., Farber J.L. Cyclosporin and carnitine prevent the anoxic death of culture hepatocytes by inhibiting the mitochondrial permeability transition. J Biol Chem. 268:1993;13791-13798.
30. Griffiths E.J., Halestrap A.P. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J. 307:1995;93-98.
31. Skulachev V.P. Why are mitochondria involved in apoptosis? Permeability transition pores and apoptosis as selective mechanisms to eliminate superoxide-producing mitochondria and cell. FEBS Lett. 397:1996;7-10.
32. Broekemeier K.M., Pfeiffer D.R. Cyclosporin A-sensitive and insensitive mechanisms produce the permeability transition in mitochondria. Biochem Biophys Res Commun. 163:1989;561-566.
33. Nicotera P., Bellomo G., Orrenius S. Calcium-mediated mechanisms in chemically induced cell death. Annu Rev Pharmacol. 32:1992;449-470.
34. Sone T., Yamada H., Endo H. Pharmacological studies of stinging caused by parabens. J Jpn Cosmet Sci Soc. 14:1990;8-16.